190 related articles for article (PubMed ID: 29674441)
1. Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).
Freedman RA; Dockter TJ; Lafky JM; Hurria A; Muss HJ; Cohen HJ; Jatoi A; Kemeny MM; Ruddy KJ
Oncologist; 2018 Sep; 23(9):1016-1023. PubMed ID: 29674441
[TBL] [Abstract][Full Text] [Related]
2. Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
Rosenberg SM; McCue S; He J; Lafky JM; Carey LA; Galanis E; Leonard JP; Meyerhardt J; Ng K; Schwartz GK; Stock W; Paskett ED; Partridge AH; George S
Cancer; 2024 Mar; 130(5):750-769. PubMed ID: 37916800
[TBL] [Abstract][Full Text] [Related]
3. Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736).
VanderWalde NA; Dockter T; Wakefield DV; Satele D; Sloan J; Jagsi R; Lichtman SM; Freedman RA; Lafky JM; Muss H; Cohen HJ; Le-Rademacher J; Jatoi A
J Geriatr Oncol; 2022 Jan; 13(1):20-26. PubMed ID: 34364834
[TBL] [Abstract][Full Text] [Related]
4. The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.
Denicoff AM; McCaskill-Stevens W; Grubbs SS; Bruinooge SS; Comis RL; Devine P; Dilts DM; Duff ME; Ford JG; Joffe S; Schapira L; Weinfurt KP; Michaels M; Raghavan D; Richmond ES; Zon R; Albrecht TL; Bookman MA; Dowlati A; Enos RA; Fouad MN; Good M; Hicks WJ; Loehrer PJ; Lyss AP; Wolff SN; Wujcik DM; Meropol NJ
J Oncol Pract; 2013 Nov; 9(6):267-76. PubMed ID: 24130252
[TBL] [Abstract][Full Text] [Related]
5. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Enrolling Older Adults Onto National Cancer Institute-Funded Clinical Trials in Community Oncology Clinics: Barriers and Solutions.
Hopkins JO; Braun-Inglis C; Guidice S; Wells M; Moorthi K; Berenberg J; St Germain D; Mohile S; Hudson MF
J Natl Cancer Inst Monogr; 2022 Dec; 2022(60):117-124. PubMed ID: 36519815
[TBL] [Abstract][Full Text] [Related]
8. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
[TBL] [Abstract][Full Text] [Related]
9. Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527.
Freedman RA; Foster JC; Seisler DK; Lafky JM; Muss HB; Cohen HJ; Mandelblatt J; Winer EP; Hudis CA; Partridge AH; Carey LA; Cirrincione C; Moreno-Aspitia A; Kimmick G; Jatoi A; Hurria A
J Clin Oncol; 2017 Feb; 35(4):421-431. PubMed ID: 27992272
[TBL] [Abstract][Full Text] [Related]
10. Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting.
Somkin CP; Ackerson L; Husson G; Gomez V; Kolevska T; Goldstein D; Fehrenbacher L
J Oncol Pract; 2013 Nov; 9(6):e275-83. PubMed ID: 24151327
[TBL] [Abstract][Full Text] [Related]
11. Creating and Implementing a Principal Investigator Tool Kit for Enhancing Accrual to Late Phase Clinical Trials: Development and Usability Study.
Higgins KA; Thomas A; Soto N; Paulus R; George TJ; Julian TB; Hartson Stine S; Markham MJ; Werner-Wasik M
JMIR Cancer; 2022 Aug; 8(3):e38514. PubMed ID: 36006678
[TBL] [Abstract][Full Text] [Related]
12. Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis.
Ledesma Vicioso N; Lin D; Gomez DR; Yang JT; Lee NY; Rimner A; Yamada Y; Zelefsky MJ; Kalman NS; Rutter CE; Kotecha RR; Mehta MP; Panoff JE; Chuong MD; Salner AL; Ostroff JS; Diamond LC; Mathis NJ; Cahlon O; Pfister DG; Zhang Z; Chino F; Tsai J; Gillespie EF
JCO Oncol Pract; 2022 May; 18(5):e780-e785. PubMed ID: 35544650
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
[TBL] [Abstract][Full Text] [Related]
15. Publication Bias in Gastrointestinal Oncology Trials Performed over the Past Decade.
Peters GW; Tao W; Wei W; Miccio JA; Jethwa KR; Cecchini M; Johung KL
Oncologist; 2021 Aug; 26(8):660-667. PubMed ID: 33728733
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey.
Canouï-Poitrine F; Lièvre A; Dayde F; Lopez-Trabada-Ataz D; Baumgaertner I; Dubreuil O; Brunetti F; Coriat R; Maley K; Pernot S; Tournigand C; Hagege M; Aparicio T; Paillaud E; Bastuji-Garin S
Oncologist; 2019 Dec; 24(12):e1351-e1359. PubMed ID: 31324663
[TBL] [Abstract][Full Text] [Related]
17. Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.
St Germain D; Denicoff AM; Dimond EP; Carrigan A; Enos RA; Gonzalez MM; Wilkinson K; Mathiason MA; Duggan B; Einolf S; McCaskill-Stevens W; Bryant DM; Thompson MA; Grubbs SS; Go RS
J Oncol Pract; 2014 Mar; 10(2):e73-80. PubMed ID: 24424313
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
[TBL] [Abstract][Full Text] [Related]
19. Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.
Schroen AT; Petroni GR; Wang H; Thielen MJ; Sargent D; Benedetti JK; Cronin WM; Wickerham DL; Wang XF; Gray R; Cohn WF; Slingluff CL; Djulbegovic B
Clin Trials; 2011 Oct; 8(5):591-600. PubMed ID: 21878447
[TBL] [Abstract][Full Text] [Related]
20. Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials.
Le-Rademacher J; Mohile S; Unger J; Hudson MF; Foster J; Lichtman S; Perlmutter J; Dotan E; Extermann M; Dodd K; Tew W; Klepin H; Wildes TM; Sedrak MS; Jatoi A; Little RF
J Natl Cancer Inst Monogr; 2022 Dec; 2022(60):135-141. PubMed ID: 36519818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
